Form 8-K - Current report:
SEC Accession No. 0001193125-23-240971
Filing Date
2023-09-25
Accepted
2023-09-25 08:56:29
Documents
15
Period of Report
2023-09-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d535787d8k.htm   iXBRL 8-K 49306
2 EX-2.2 d535787dex22.htm EX-2.2 108434
3 EX-3.1 d535787dex31.htm EX-3.1 11353
4 EX-3.2 d535787dex32.htm EX-3.2 75615
  Complete submission text file 0001193125-23-240971.txt   432563

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dbtx-20230925.xsd EX-101.SCH 2856
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbtx-20230925_lab.xml EX-101.LAB 19482
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbtx-20230925_pre.xml EX-101.PRE 12157
9 EXTRACTED XBRL INSTANCE DOCUMENT d535787d8k_htm.xml XML 3678
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40030 | Film No.: 231273214
SIC: 2834 Pharmaceutical Preparations